Transmigration of PBMNCs from β-IFN-lb-Treated MS Patients: a One-Year Longitudinal Study

References

• Dorman JS. Molecular epidemiology of insulin-dependent diabetes mellitus. Epidemiol Rev 1997: 19: 91–98.
   Google Scholar
• Akerblom HK, Knip M, Hyoty H, Reijonen H, Virtanen S, Savilahti E, Ilonen J. Interaction of genetic and environmen-tal factors in the pathogenesis of insulin-dependent diabetes mellitus. Clin Chim Acta 1997: 257: 143–156.
   Google Scholar
• Kolb H, Pozzilli P. Cow’s milk and type 1 diabetes: the gut immune system deserves attention. Immunology Today 1999: 20: 108–110.
   Google Scholar
• Dahlquist G. The aetiology of type 1 diabetes: an epidemio-logical perspective. Acta Paediatr 1998: 425: 5–10.
   Google Scholar
• Perez-Bravo F, Serrano-Rios M, Gutierrez-López MD, Calvillán M, Garcia de los Rios M, Kocova M, Dorman IS, Trucco M. Genetic analysis of HLA DRB1, DQA1 and DQB1 alleles and susceptibility to IDDM in Chilean sub-jects. Diabetologia 1995: 38: 378-379.
   Google Scholar
• Perez-Bravo F, Carrasco E, Gutierrez-López MD, Martinez MT, LiSpez G, Garcia de los Rios M. Genetic predisposition and environmental factors leading to the development of insulin-dependent diabetes mellitus in Chilean children. J. Mol. Med. 1996: 74: 105–109.
   Google Scholar
• Carrasco E, Perez-Bravo F, Santos JL, Lopez G, Calvillán M, Wolff C, Garcia de los Rios M. One of the lowest validated incidence rates of insulin dependent diabetes mellitus in the Americas: Santiago, Chile. Diab. Res Clin Pract 1996: 34 (Suppl): 153-157.
   Google Scholar
• Santos IL, Schaid D, Perez-Bravo F, Carrasco E, Calvillán M, Albala C. Applicability of the case-parent design in the etiological research of type 1 diabetes in Chile and other genetically mixed populations. Diab Res Clin Pract 1999: 43: 143–145.
   Google Scholar
• Khoury Mi. Case-parental control method in the search for disease-susceptibility genes. Am. J. Hum. Genet 1994: 55: 410–415.
   Google Scholar
• Schaid DJ. Case-parents design for gene-environment inter-action. Genetic Epi 1999: 6: 261–273.
   Google Scholar
• Bingley PJ, Bonifacio E, Gale EAM. Can we really predict IDDM?. Diabetes 1993: 42: 213–220.
   Google Scholar
• Bonifacio E, Genovese S, Braghi S, Bazzigaluppi E, Lampa-sona V, Bingley Pi, Rogge L, Pastore MR, Bognetti E, Botazzo GF, Gale EAM, Bosi E. Islet autoantibody markers in IDDM: risk assessment strategies yielding high sensituv-ity. Diabetologia 1995: 38: 816–822.
   Google Scholar
• Sabbah E, Savola K, Kulmala P, Reijonen H, Veijola R, Vahasalo P, Karjalainen J, Ilonen J, Akerblom HK, Knip M. Disease-associated autoantibodies and HLA-DQB1 genotypes in children with newly diagnosed insulin-dependent diabetes mellitus (IDDM). Clin Exp Immunol 1999: 116: 78–85.
   Google Scholar
• Leslie RDG, Atkinson MA, Notkins AL. Autoantigens IA-2 and GAD in type 1 (insulin-dependent) diabetes. Diabetolo-gia 1999: 42: 3–14.
   Google Scholar
• Miller SA, Dikes DD, Polesky HF. A simple salting out pro-cedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988: 16: 1215.
   Google Scholar
• Sambrook J, Fritsh EF, Maniatis TM. Molecular cloning. A laboratory manual. 2nd edn. Cold Spring Harbor Lab. Press, 1989.
   Google Scholar
• Bodmer JG, Marsh SG, Albert DE, Bodmer WF, Dupont B, Erlich HA, Mach B, Mayr WR, Parham P, Sasazuki T. Nomenclature for factors of the HLA system, 1994. Hum Immunol 1994: 41: 1–41.
   Google Scholar
• Morales J, Puig-Domingo M, Lampasona V, Corcoy R, Dyr-berg T, Mauricio D, Bonifacio E, de Leiva A. Can we replace ICA?. Risk assessment by using fluid phase multiantibody analysis in a prediabetic Spanish cohort. Av Diabetol 1998: 14: 91–98.
   Google Scholar
• Pilcher CC, Elliot RB. A sensitive and reproducible method for the assay of human islet cell antibodies. J Immunol Meth-ods 1990: 129: 111–117.
   Google Scholar
• Eyspasch E, Lefering R, Kum CK, Troidl H. Probability of adverse events that have not yet occurred: a statistical reminder. Br Med J 1995; 311: 619 — 620.
   Google Scholar
• Schaid DJ. Transmission disequilibrium, family controls and great expectations. Am J Hum Genet 1998; 63: 935 — 941.
   Google Scholar
• Santos IL, Perez-Bravo F, Piquer S, Puig-Domingo M, Car-rasco E, Calvillán M, De Leiva A, Albala C. Assessment of the interaction between HLA-DQB1 alleles and GAD65 in a study of cases and parents in Chile. Diabetologia 1999; 42: A–92.
   Google Scholar
• Schaid DJ. Case-parents design for gene-environment inter-action. Genetic Epidemiology 1999; 16: 261 —273.
   Google Scholar
• Whitte JS, Gauderman WJ, Thomas DC. Asymptotic bias and efficiency in case-control studies of candidate ganes and gene-environment interactions: basic family designs. Am. J. Epidemiol. 1999; 149: 693 —705.
   Google Scholar
• Zelczer D, Wong S. Ayalon 0, Millet I, Altieri M, Shintani S, Solimena M, Sherwin RS. GAD-reactive CD4+ Th 1 induce diabetes in NOD/SCID mice. J Clin Invest 1998: 101: 68-73.
   Google Scholar
• Atkinson MA, Bowman MA, Campbell L, Darrow BL, Kaufman DL, Maclaren NK. Cellular immunity to a determi-nant common to glutamate decarboxilase and coxsackie virus in insulin-dependent diabetes. J Clin Invest 1994: 94: 2125–2130.
   Google Scholar
• Bingley PJ, Bonifacio E, Williams AJK, Genovese S, Bot-tazzo GF, Gale EAM. Prediction of IDDM in the general population: strategies based on combination of autoantibody markers. Diabetes 1997: 46: 1701–1710.
   Google Scholar
• Tian J, Olcott A, Hanssen L, Zelczer D, Kaufman DL. Anti-gen-based immunotherapy for autoimmune disease: from animal model to humans?. Immunol Today 1999: 20 (4): 190–194.
   Google Scholar
• Strebelow M, Scholosser M, Ziegler B, Rjasanowski I, Zie-gler M. Karlsburg type 1 diabetes risk study of a general pop-ulation: frequencies and interactions of the four major type 1 diabetes-associated autoantibodies studied in 9419 school-children. Diabetologia 1999: 42: 661–670.
   Google Scholar